Cysticercosis

• CLINICAL_TRIALS research · 2026-03-31
  Clinical Trial Update: Natural History of Treated Neurocysticercosis and Long-Term Outcomes

  This clinical trial update outlines the natural history of treated neurocysticercosis and investigates long-term outcomes in affected indivi…

• FDA approval · 2023-12-19
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) to update the label with expanded indications for treating helminth in…

• FDA approval · 2019-01-08
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals Inc. This approval results in an…

• CLINICAL_TRIALS trial_result · 2018-04-03
  Clinical Trial Update: EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso [NA]

  This clinical trial update notes the completed EFECAB study in Burkina Faso evaluating improved pig management to reduce cysticercosis and p…

• CLINICAL_TRIALS trial_result · 2017-07-02
  Clinical Trial Update: Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis

  This completed clinical trial investigated brain swelling and seizure activity associated with inactive cysticercosis. The update highlights…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2016-08-30
  Clinical Trial Update: Single Ascending Dose Safety Study of Oxfendazole [Phase 1]

  The clinical trial update indicates that a Phase 1 single ascending dose safety study of oxfendazole for Taenia solium infection has been wi…

• CLINICAL_TRIALS trial_result · 2015-02-11
  Clinical Trial Update: Taenia Solium Control Case Study in Zambia [NA]

  A completed clinical trial update from NCT01368354 detailing Taenia solium control efforts in Zambia, focusing on cysticercosis and helminth…